Spatial Transcriptomic Analysis Identifies a SERPINA3-Expressing Astrocytic State Associated with the Human Neuritic
Berke Karaahmet1, Ya Zhang1, Laurine Duquesne1
1Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA.
Biorxiv : the Preprint Server for Biology
|November 28, 2024
Summary
Researchers identified SERPINA3+ astrocytes (Ast.5) near amyloid plaques in Alzheimer's disease. This study maps gene expression changes in the brain's architecture, revealing new cellular players in neurodegeneration.
Area of Science:
- Neuroscience
- Genomics
- Pathology
Background:
- Single-nucleus transcriptomics identified glial cell states in Alzheimer's disease (AD).
- These studies lack spatial context within the human neocortex architecture.
Purpose of the Study:
- To analyze spatially-registered transcriptomic data using an unbiased, distance-based strategy.
- To identify genes and cell types altered in the vicinity of neuritic amyloid plaques in AD.
Main Methods:
- Spatially-registered transcriptomic analysis.
- Immunohistochemistry for validation in tissue sections.
- Immunofluorescence for protein-level validation.
Main Results:
- SERPINA3 and metallothionein genes were prioritized as altered near amyloid plaques.
- A reactive SERPINA3-positive astrocyte subtype (Ast.5) was identified.
- Ast.5 cells play a role in the amyloid plaque microenvironment.
Conclusions:
- The study provides spatial context to glial cell states in Alzheimer's disease.
- SERPINA3+ astrocytes (Ast.5) are a key component of the plaque microenvironment.
- This highlights potential therapeutic targets within the AD brain pathology.
